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Abstract 
The present study of salivary mucin MUC5B has sought to isolate and evaluate 
the properties of peptide constructs derived from within the cystine-knot motif. Three 
peptide constructs of different lengths were designed from the C-terminal sequence of 
MUC5B and each construct incorporated restriction sites for the endonucleases BamHI, 
at their 5' end, and Xhol at their 3' end. Amplification was accomplished using RT-PCR, 
with cDNA for the RT reaction derived from RNA isolated from frozen human 
submandibular glands. Constructs were cloned in to E. coli using a TOPO vector and 
cultured in order to isolate plasmid inserts that were then ligated into a pGEX-5X-2 
vector. BL21 E. coli were utilized as host cells, using the pGEX-5X-2 vector to 
transform the construct plasmids. Protein expression was then induced in the host cells 
using IPTG and the GST fusion-protein product collected via centrifugation of the 
sonicated cell pellets. Fusion proteins were then isolated using Sepharose 4B affinity 
column purification. Isolates were finally dialyzed against deionized water and 
lyophilized; the lyophilate was then intended for immunization of rabbits. Fusion protein 
isolation required extensive optimization, including the reduction of sonication cycles 
and the addition of protease inhibitors in order to reduce the action of host cell enzymes 
on the protein product. Attempts to cleave constructs from their GST fusion partners 
were unsuccessful due to the possible effects of intramolecular folding during expression 
that may have blocked the enzyme recognition site. Denaturants were employed in order 
to improve enzyme-protein interaction, however, colorimetric assays revealed that even 
suggested levels of these chemicals significantly reduced the activity of the cleavage 
enzyme. 
V 
It is hoped that immunological studies using the purified MUC5B construct fusion 
proteins will provide beneficial information on the C-terminal cystine-knot motif, in 
particular, its bonding characteristics that are believed to be essential in the formation of 
mucin dimers and multimers. 
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1. Introduction 
1.1 Basic Characteristics and Physiology of Oral Tissues and Saliva. 
Several tissues in the human body utilize mucosal secretions that line the 
epithelial surfaces of the respiratory, gastro-intestinal, and urogential tracts. These 
linings, also known as mucous membranes, often lack keratinization when necessitated 
by functional requirements for absorption and secretion (Selvaratnam et al., 2001 ). The 
oral cavity, in particular, is composed of a variety of tissues, including mucosal 
epithelium (Hatton et al., 1985). Among its many functions, the oral cavity serves as the 
initial location for digestion and possesses several general types of mucosa: lining, 
masticatory, and specialized (Tabak et al., 1982). The glandular tissues that exist within 
the oral cavity produce saliva as their primary secretory product (Bradway et al., 1992). 
The properties of salivary secretions are of great interest to oral biologists due to their 
effect on the function of oral tissues and host defense against mechanical injury and oral 
microbes (Gibbons and Qureshi, 1978). 
Saliva contains more than 40 different proteins, including a number of non-
glycosylated and glycosylated families, which can be classified as mucinous and non-
mucinous forms. The primary non-mucinous proteins found in saliva include the 
following. Histatins are antimicrobial peptides possessing cell-killing ability against the 
opportunistic yeast, Candida albicans, by means of interfering with membrane integrity 
and target metabolism (Oppenheim et al., 1988). Statherin, an acidic phosphoprotein, 
inhibits the nucleation and accumulation of calcium phosphate salts in addition to its 
function as a boundary lubricant (Ramasubbu et al., 1993; Schlesinger and Hay, 1977). 
L ysozyme possesses an antimicrobial function by hydrolyzing glycosidic bonds in 
1 
bacterial cell walls (Eshdat and Sharon, 1977). Praline-rich proteins act to protect oral 
surfaces and are components of the acquired enamel pellicle, allowing them to affect the 
mineralization-demineralization process (Al-Hashimi and Levine, 1989). Kallikrein is a 
serine protease that allows the release of kinins, necessary in regulating local blood flow, 
tissue metabolic rate, and the production of pain and inflammatory responses in the oral 
cavity (Bhoola et al., 1992; Schachter, 1983). Haptocorrin binds vitamin B-12 and is 
proposed to have some bacteriostatic properties (Sandberg et al., 1981; Samson et al., 
1980). Fibronectin is an extracellular matrix protein, which regulates angiogenesis and 
vasculogenesis (Zhao and Eghbali, 2001 ). Agglutinin, a blood group reactive 
glycoprotein, serves to clear microorganisms from the oral cavity by binding bacteria 
(Ligtenberg et al., 2000; Rundegren and Ericson, 1981 ). Secretory IgA has several 
antimicrobial functions, including virus neutralization, bacterial enzyme inhibition, and 
blocking epithelial binding sites to prevent bacterial colonization (Kilian and Russell, 
1994). Praline-rich Glycoprotein is able to bind calcium and has a high affinity for 
hydroxyapatite, allowing it the capacity to adhere to hard tissues, forming intra-oral 
pellicles (Scannapieco, 1994; Bennick, 1982). Carbonic Anhydrase functions mainly as a 
buffer under conditions of acidic pH; by binding to the pellicle on tooth enamel, it is 
optimally located in order to convert bicarbonate and hydrogen ions, secreted from 
microbes, to carbon dioxide and water (Kivela et al., 1999). Peroxidase possesses an 
antibacterial function, by the catalysis of SCN and hydrogen peroxide to cytotoxic 
thiocyanates; it also serves to neutralize hydrogen peroxide and reduces acid secretion by 
dental microbes. Lactoferrin is another antibacterial protein due to its ability to bind iron, 
essential for oral microbe nutrition (Scannapieco, 1994). Amylase, the most abundant 
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protein in saliva, occurs in glycosylated and non-glycosylated forms; it functions as a 
metalloenzyme, hydrolyzing glycosidic bonds in starches, and recent studies indicate that 
amylase may also inhibit the growth of several bacterial species (Schenkels et al., 1995; 
Scannapieco, 1994; Cohen and Levin, 1989). 
1.2 Secretion of Mucins 
The process of protein synthesis is a complex interaction of several hundred 
macromolecules, including mRNA, rRNAs, tRNAs, aminoacyl-tRNA synthetases, and 
protein factors. Ribosomes, consisting of large and small subunits, are the primary site of 
protein synthesis, as amino acid constituents are assembled from their amino- to 
carboxyl-end within the cell cytoplasm or the rough endoplasmic reticulum (Berg et al., 
2002). In the case of salivary mucins, the cells responsible for mucin secretion are the 
acinar cells and, occasionally, ductal cells, found within the various salivary gland tissues 
of the oral cavity, most notably the major salivary glands of the submandibular and 
sublingual, in addition to numerous minor salivary glands. (Ten Cate, 1998). The parotid 
glands are exclusively serous, while the submandibular glands contain a mixture of 
serous and mucinous acini and the sublingual glands are primarily composed of mucous 
secreting acini (Ten Cate, 1998). 
The primary polypeptide backbones of mucins are modified within the lumen of 
the endoplasmic reticulum (ER) and in the Golgi complex. Within the ER, glycosylation 
of mucins is accomplished by the attachment of sugars to the amide-group in asparargine, 
termed as N-linked. While N-glycosylation occurs primarily within the ER, the Golgi 
complex acts to alter and elaborate the carbohydrate units, in addition to forming 0-
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linked sugars by the attachment of glycans to the hydroxyl-group of serine or threonine. 
The type and proportion of N- or O-linked attachments is dependent on the protein 
structure and cell type. The Golgi complex itself consists of a cis, or receiving 
compartment, a medial compartment, and a trans, or export compartment. Once through 
the Golgi complex, proteins are transported to lysosomes, secretory granules, or the cell 
membrane (Berg et al., 2002). Mature, inactive proteins, or zymogens, are released in to 
the lumen of the glandular acinus, by exocytosis, and then secreted in to the oral cavity in 
their active form by contractile cell action (Ten Cate, 1998). 
1.3 Physiology and Structure of Mucins. 
Mucous is composed of proteins, water, and several orgamc and inorganic 
substances that engender this epithelial coating substance with unique viscoelastic and 
rheological properties (Bansil et al., 1996). Among its many functions in the oral cavity, 
mucous provides a protective barrier against toxic substances, mechanical stress, and 
intrusion of microbes; further, it can function as a lubricant to reduce friction for food 
passage and the abrasion of contacting tissues during mastication and speech. Mucous 
also serves as a transport mechanism, carrying with it inorganic salts necessary for 
enamel mineralization and secretory immuno-globulins, namely IgA, which have 
antibacterial properties (Tabak, 1995). MG 1 and MG2, the two primary mucinous 
proteins, are capable of binding to hydroxyapatite, and may constitute part of the 
acquired enamel pellicle (Tabak et al., 1982; Al-Hashimi and Levine, 1989). It is this 
enamel pellicle that is capable of adhering to a large group of microorganisms, including 
cariogenic strains of Streptococcus mutans (Liu et al., 2000). 
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Mucinous proteins, or mucms, share a number of common structural 
characteristics, in addition, each mucin assumes a distinct tissue distribution, meaning 
that a gene for a given mucin is always expressed more in one particular tissue than 
another. These tissue distributions are known to overlap, however, allowing several 
mucins to exist in the mucinous coating of a given epithelial surface (van Klinken et al., 
1995). Primarily, mucins are composed of a variety of heavily glycosylated proteins, 
approximately 15-20% protein and 80% carbohydrate, existing largely in the form of O-
linked glycans (Strous and Dekker, 1992; Gendler and Spicer, 1995). The O-linked 
glycans provide mucins with their unique characteristics and functions. A mucin' s 
polypeptide backbone possesses three distinct regions with a central tandem repeat that 
contains a high concentration of serine, threonine, and proline; tandem repeats of human 
mucins have lengths of 8 to 169 amino acids (Offner and Troxler, 2000). 
There are three distinct classes of mucins, membrane-bound-MUCl, MUC3, 
MUC4, and MUC12; gel-forming-MUC2, MUC5AC, MUC5B-also known as MGl; 
and a smaller soluble mucin, MUC7-formerly known as MG2. The monomeric forms 
of these mucins have molecular weights in excess of 2 million Daltons. Not all mucins 
may fall in to these categories; MUC8 and MUC11 have not been characterized 
sufficiently to be classified under any of the three primary mucin groups. Membrane-
bound mucins are thought to possess significantly different structural properties from 
their gel-forming counterparts due to their inability to form high molecular weight 
polymers (Offner and Troxler, 2000). 
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Table 1-1. Classes of Mucinous Proteins 
Gel-forming 
MUC2 
MUC5AC 
MUC5B 
MUC6 
Membrane-bound 
MUCl 
MUC3 
MUC4 
MUC12 
1.4 Characteristics of MU C5B. 
Soluble 
MUC7 
Particular to this study, are the properties of MUC5B, which, in conjunction with 
MUC4, produces a mixture of gene products found in MG 1, one of two mucins secreted 
by the sublingual and submandibular glands (Liu et al., 1998). The products of mucin 
secretion form complexes with other salivary proteins, and MUC5B contains binding 
domains for statherin and histatins. MUC5B is one of four gel-forming mucins whose 
proteins exist as polymers with molecular weights in excess of 20-40 million Daltons 
(Troxler et al., 1997). 
Like other gel-forming mucms, MUC5B contains a central reg10n of nearly 
identical 29-residue tandem-repeats enriched with serine, threonine, and praline, 
interrupted by seven short cysteine-rich domains (Desseyn et al., 1997). The tandem 
repeat of MUC5B contains a total of 3570 amino acids. Located at either end of the 
central region are an N- and a C- terminal region, consisting of 1321 and 805 amino acids 
respectively (see Figure 1-1 ). The tandem-repeat region functions as the attachment site 
for O-linked glycans. The N- and C- terminal regions of human mucins are weakly or 
probably sparingly N-glycosylated (Gendler and Spicer, 1995; van Klinken et al., 1995). 
The N-terminal region possesses 3 distinct cysteine-rich domains, D1, D2, and D3, that 
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resemble those found in pre-pro von Willebrand factor in humans (Gum et al., 1994; 
Toribara et al., 1994; Li et al., 1997; Offner et al., 1998; van de Bovenkamp et al., 1998). 
In addition , MUC5B , along with MUC2 and MUC5AC , contains a D4 domain in its C-
terminal region , downstream of the tandem repeat domain , along with a characteristic 
cystine knot motif (Gum et al., 1992, 1994; Meerzaman et al., 1994; Keates et al., 1997; 
Troxler et al., 1997). The position of cysteine residues in gel forming mucins is nearly 
identical to that in von Willibrand factor. 
N 
N-terminal 
1321 aa ( . ) .<a 1321 ammo ac1 s 
ROI R02 
Dl D2 D3 Cl C2 C3 
tandem repeat 
3570 aa 
3570 amino acids 
R1 RJI RJII 
C4 cs 
C-terminal 
805 aa 
~~5 amino acids 
RJV RV 
D4 
8a 8b 8c 
C 
Fig. 1-1 Structure of MUC5B. Cysteine-rich domains (gray), tandem repeat (black), 
and c stine knot ( dia onal hatch . 
1.5 Cystine Knot Motif 
Located at the extreme C-terminal end of MUC5B , the cystine knot motif is of 
particular interest in this study. The initial identification of a consensus cysteine 
framework occurred when mammalian endothelin and insect-derived neurotoxins were 
studied , forming the necessary basis for a homologous folding motif (Tamaoki et al., 
1991, and Kobayashi et al., 1991 ). Proteins known to possess a cystine knot include a 
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superfamily of the following: transforming growth factor-P, glycoprotein hormone, and 
platelet-derived growth factor subfamilies. Several subfamilies of proteins have also 
been identified with a cystine knot , including: mucins, Norrie disease protein, bone 
morphogenetic protein antagonists, slit-like proteins, and von Willebrand factor (Vitt et 
al., 2001 ). Based on studies of gall bladder mucin, later identified as a MUC5B gene 
product, genetic structural analysis has shown that there is a significant similarity 
between the intron-exon junction positions in the D4 domain of MUC5B and von 
Willibrand factor (Keates et al., 1997). 
Typically, the cystine knot is composed of a characteristic ring structure ( see 
Figure 1-2) containing eight amino acids, four of which are disulfide-bound cysteine 
residues; this eight unit ring is common to all proteins within the cystine knot superfamily 
(Tamaoki et al., 1998). Intertwined within the basic ring is a second ring, containing two 
additional cysteines unique to each protein family, that forms a looped structure. In total, 
the loop-and-ring structured cystine knot contains 10 amino acids, including 6 cysteine 
residues (McDonald and Hendrickson, 1993). Functionally, the cystine knot is important 
in MUC5B, since it is the cysteine residues that link mucin monomers that may act to 
guide the folding of the secreted protein, avoiding a globular structure typical in aqueous 
solutions. The resulting structure possesses exposed hydrophobic residues that facilitate 
protein-protein interactions (Xu et al., 2000). 
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Fig. 1-2 Cystine knot structure from Vitt et 
al., 2001. 
Previous studies of porcine submaxillary mucm have led to a model for the 
formation of mucin dimers and multimers (Perez-Vilar and Hill, 1998). Mucin dimers 
are formed by the disulfide bonds between certain cysteine residues contained within the 
cystine knot motif of each monomer. The process of dimerization occurs in the ER, after 
which N-linked glycans are added followed by 0-glycosylation in the cis-Golgi. 
Disulfide-linked oligomers display preferential expression in the non-acidic environment 
of the ER and the cis- and medial-compartments of the Golgi complex (Orsi et al., 1986). 
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Cysteine rich domains , D 1, D2, and D3 within the N-terminal region, allow 
trimerization of MUC5B through disulfide bonding of dimers as they pass through the 
trans-Golgi before secretory granules are formed. It has been speculated that these mucin 
trimers may produce more complex polymers or they may bind to other gel-forming or 
membrane-bound mucins such as MUCl and MUC4. These heterogenic polymers may 
function as a structural foundation upon which MUC5B can aggregate (Offner and 
Troxler, 2000). 
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2. Objectives 
The purpose of this investigation was to: 
1) Identify the cystine knot motif located within the C-terminus of MUC5B and isolate 3 
amino acid sequence constructs for study. 
2) Synthesize the 3 constructs from their PCR amplified ammo acid sequences by 
transforming them in to E. coli cells and collecting the induced protein product. 
3) Isolate the 3 construct proteins by affinity purification and produce 1mg of pure 
protein for use in antibody production . 
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3. Materials and Methods 
3.1 Preparation of MUCSB Constructs 
The deduced amino acid sequence for the C-terminal region of MUC5B was 
located on the website of the National Center for Biotechnological Information (NCBI; 
Accession number XM 039877). Sequences of MUC5B were selected, starting from 
nucleotides 2234, 2362 and 2461 and continuing to the C-terminal codon; these 
nucleotides encode the C-terminal 151, 108 and 75 amino acids. Throughout this study, 
the constructs will be referred to by their respective amino acid size. 
In order to allow for cloning into the appropriate expression vector, Barn Hl 
(GGATCC) and Xho 1 (CTCGAG) restriction sites were incorporated into 5' and 3' 
primers to be used for PCR amplification of cDNA. The nucleotide sequences of the 
primers used to amplify sequences encoding the C-terminal 151, 108 and 75 residues of 
MUC5B are shown in Table 3-1. 
3.2 mRNA Isolation 
Human submandibular gland tissue (1 g) was placed in 15 mL of FT® 2.0 Lysis 
buffer (200 mM NaCl, 200 mM Tris-HCl pH 7.5, 1.5 mM MgCb, 2% SDS, and 2% 
Protein/RNase Degrader) in a 50 ml Falcon tube, homogenized for 30 sec using a 
Polytron macerator (Brinkmann Instruments, Rexdale, Ontario), and the sample was 
incubated 45°C for 60 min. The lysate was adjusted to 0.5 M with respect to NaCl by the 
addition of 5 M NaCl followed by gentle inversion. DNA in the lysate was sheared by 
passing the sample through a sterile plastic syringe fitted with an 18-21 gauge needle 
three to four times. Oligo( dT) cellulose was added to the lysate and allowed to swell for 2 
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Table 3-1. MUCSB primers with restriction sites. BamHl 
and Xhol restriction sites on Forward and Reverse primers are shown in 
bold face type. 
151 Forward 
5'TGACTAGGATCCAGAACTGCACCGTGTACCTCTGT 
108 Forward 
5'TGACTAGGATCCAGGAGGACTCCTGTCAAGTCCGC 
75 Forward 
5'TGACTAGGATCCAGGCGTCCAAGTACTCAGCAGAG 
Reverse Primer 
5'AGATCTCGAGTCAGACAGCAGTGGCCTCCTGGG 
13 
mm. Subsequently, the lysate was gently agitated on a platform rocker at room 
temperature for 60 min. The sample was centrifuged at 3000 x g for 5 min at room 
temperature and the supernatant removed carefully. The oligo( dT) cellulose pellet was 
then gently suspended in 20 ml of binding buffer (500 mM NaCl, 10 mM Tris-HCl, pH 
7.5 in DEPC-treated water) and centrifuged at 3,000 x g for 5 min at room temperature . 
The oligo( dT) cellulose pellet was washed three times in the binding buffer as above and 
resuspended in 10 ml of low salt wash buffer (250 mM NaCl, 10 mM Tris-HCl pH 7 .5 in 
DEPC-treated water) followed by centrifugation at 3,000 x g for 5 min at room 
temperature. Resuspension in the low salt wash buffer was repeated 3 times until bubbles 
were no longer observed in the sample after centrifugation. 
After the last wash, the oligo( dT) cellulose was resuspended in low salt wash 
buffer with a final volume of 800 µl, transferred into a spin-column and centrifuged at 
5,000 x g for 10 sec at room temperature. The column was then removed from the 
microcentrifuge tube and the supernatant was decanted. The spin-column was placed 
back into the tube, 500 µl of low salt wash buffer was added using a sterile pipette tip and 
the sample was then centrifuged for 10 sec at room temperature. The last two steps were 
repeated three times until the OD260 of the "flow-through" was less than 0.05. 
3.3 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
PCR products encoding the C-terminal 151 residues of MUC5B were amplified 
from submandibular gland mRNA using unique forward (5') and reverse (3') primers 
(Table 3-1). Reagents for RT were thawed on ice and the reaction mixtures were prepared 
in small Eppendorf tubes immersed in ice. The reverse transcriptase reaction contained: 
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submandibular gland mRNA (1 µl; 1 µg/µl), 5x RT buffer (4 µl; 250 mM Tris-HCl, pH 
8.3, 375 mM KCl, 15 mM MgCh), unique primers (1 µl; 10 pmol/gl), dNTPs (2 µl; 10 
mM stock solution), 0.1 M DTT (1 µl), RNAsin (0.5 µl), MML V reverse transcriptase (1 
µl; 200 units/µl). The reaction mixture was incubated at 37°C for 1-2 hr. 
PCR was performed using 50 µl reactions in small Eppendorf tubes on an MJ 
Research thermal cycler (model PCT-100). 50 µl of mineral oil was added to the top of 
each reaction mixture prior to performing PCR. The cycler program used is given in 
Table 3-2 and the composition of PCR reactions is given in Table 3-3. 
In order to obtain a sufficient quantity of DNA, two reactions were used for the 
initial PCR. Reaction mixtures containing DNA products were examined 
electrophoretically on 0.7% agarose gels that were prepared as follows: 0.7 g of agarose 
(UltraPure™; Life Technologies #15510-027) was added to 100 ml of lx TAE buffer (70 
mM Tris-acetic acid, pH 8.0, containing 2 mM EDTA and water). The agarose solution 
was heated to 100°C in a microwave oven, cooled to 56°C and 1.5 µl of ethidium-
bromide (10 mg/ml in water) added and the mixture poured into a flat bed gel tray. 10 µl 
of 6x DNA buffer (0.25% Bromophenol Blue, 0.25% w/v xylene cyanol, 15% Ficoll in 
water) was added to each 50 µl PCR reaction, samples were then loaded in wells and 
electrophoresis was performed in 1 x T AE buffer at 100 V for 45 min. The agarose gels 
were examined on a UV light box and the size of the PCR product encoding the 151 C-
terminal residues of MUC5B was approx. 450 bp when estimated by reference to a 1 kb 
ladder (lnvitrogen #10787-018, 1.0 µg/µl). 
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Table 3-2. PCR program for amplification of submandibular 
gland cDNA. 
Step Temperature (°C) Time (min) 
1 94.0 3.00 
2 94.0 0.83 
3 60.0 0.83 
4 72.0 1.50 
5 repeat 2-4, 38 times repeat 2-4, 38 times 
6 72.0 10.00 
7 4.0 10.00 
Table 3-3. Composition of PCR reactions. 
1) 3 7 .5 µI deionized water 5) 1.0µ1 5' primer (10 pmol) 
2) 5.0 µl l0x buffer* 6) 1.0µ13' primer (10 pmol) 
3) 3.0 µI MgCh 7) 1.0µ1 RT reaction of 151 plasmid DNA 
4) 1.0 µI dNTP (10 mM) 8) 0.5µ1 Taq polymerase (1 U/µl) 
*l0X buffer: 500 mM KCI, 100 mM Tris-HCI (pH 9.0), 1 % Triton X-100 
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3.4 DNA Construct Isolation 
The 450 bp PCR product was extracted from agarose gels usmg a Qiagen 
QIAquick Gel Extraction Kit. Bands were excised with a clean scalpel and the gel slices 
were weighed in a colorless tube, followed by the addition of three volumes of Buffer QG 
(guanidine-thiocyante and pH indicator) to one volume of each agarose gel slice (i.e., 100 
mg gel to 100 µl buffer). Gel slices were then incubated at 50°C until fully dissolved; 
during incubation, solutions were mixed by inverting the tubes every 2-3 min. After the 
gel slices were dissolved, the color each solution was observed, with yellow indicating an 
optimal pH of 7 .5 or less. One gel volume of isopropanol was then added to each gel 
solution and mixed gently. 
Samples were added to QIAquick spin columns and centrifuged at 14,000 x gin 
an Eppendorf centrifuge (#5415 C) for 1 min at room temperature. Flow-throughs were 
then discarded and columns were placed back into the same collection tubes. Columns 
were then washed by adding 0.75 ml of Buffer PE (10 mM Tris-HCl, pH 7.5, 5% ethanol) 
and centrifuged again for 1 min. Flow-throughs were discarded and the columns re-
centrifuged at 10,000 x g for 1 min. Finally, columns were placed into a clean 1.5 ml 
Eppendorf tubes, 50 µl of deionized water was added to elute DNA and the tubes 
centrifuged again for 1 min at 14,000 x g. The resulting DNA corresponding to the 151 
construct was taken up in water and stored at -80°C until used. 
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3.5 TOPO Cloning Reaction and Transformation 
The purified 450 bp DNA sample was ligated into the pCR®2.l-TOPO ® vector 
(Invitrogen; # K4500-01) and the ligation reactions were used to transform E. coli. 
Ligations and transformations were performed according to manufacturer's protocols 
(Invitrogen). Ligation reactions contained 4 µl of each DNA sample, 1 µl of ligation 
buffer (1.2 M NaCl and 0.06 M MgCh) and 1 µl of TOPO vector with covalently bound 
Topoisomerase I. The samples were gently mixed and incubated for 5 min at room 
temperature before being placed on ice. Transformation reactions contained 2 µl of 
ligation reaction gently mixed with one vial of One Shot® Chemically Competent E. coli. 
The samples were then incubated on ice for 30 min and the cells then heat-shocked for 30 
sec at 42°C. Heat shocked samples were placed immediately on ice and 250 µl of SOC 
medium was then added. Sample tubes were capped and shaken at 200 rpm in a 
horizontal position for 1 hour at 37°C. Subsequently, 50 µl of each transformation 
reaction was spread on to a separate pre-warmed LB/ampicillin plate. The remaining 200 
µl of each transformation sample was then spread on a second LBA/ampicillin plate and 
all plates were incubated overnight at 3 7°C. 
LB/ampicillin plates were made as follows: 10 g tryptone, 5 g yeast extract, 10 g 
of NaCl, and 20 g agar added to 900 ml of deionized water. The volume was then 
adjusted to 1 1, followed by sterilizing using an autoclave at 180°C at 15 psi for 20 min. 
The medium was then cooled to 50°C before aseptically adding 1 ml of 100 mg/ml 
ampicillin stock solution to yield a final concentration of 100 µg/ml. The medium was 
finally poured in to small petri dishes and allowed to solidify. 
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In order to confirm the successful cloning of the 151 construct, 8 colonies from 
LB/amp plates were used as template for PCR. Six blue colonies and 2 white colonies 
were selected. Blue colonies indicate a successfully transformed cell colony containing 
the TOPO DNA whereas white colonies indicate that a blunt-ended ligation has occurred, 
disrupting the LacZa reading frame for transformation. 
A master mix for PCR reactions was prepared (Table 3-4) and portioned in 25 µl 
aliquots into 8 small Eppendorf tubes. Selected colonies from LB/amp plates used as 
PCR reaction templates were then placed in to each reaction mixture with the aid of a 
sterile pipette tip. 
25 µl of mineral oil was added to the top of each reaction and sample were added 
to wells in the thermal cycler. The PCR program used was: 94 °C for 3 min, 94 °C for 50 
sec; 60°C for 50 sec, 72°C for 1.5 min; repeat step 2-4 38 times; 72°C for 10 min, 4°C for 
12 h. When the PCR reaction was completed samples were removed with a pipette tip 
and combined with 5 µl of 6x DNA buffer and electrophoresed in a 0.7% agarose gel as 
described in Section 3.2. The gel was examined under ultraviolet light to verify the 
correct size of amplified DNA. 
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Table 3-4. TOPO PCR master mix. 
1) 365 µl deionized water 5) 10 µI forward primer ( 10 pmol) 
2) 50 µl 1 Ox buffer* 6) 10 µI reverse primer (10 pmol) 
3) 30 µ110 mM MgCh 7) 5.0 µI Tag polymerase (1 U/µl) 
4) 10 µ110 mM dNTP (10 nM) 
*lOX buffer: 500 mM KCI, 100 mM Tris-HCI (pH 9.0), 1 % Triton X-100 
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3.6 Plasmid Extraction 
Two colonies containing the 151 construct were inoculated into 5 ml LB medium 
containing ampicillin (100 ug/ml) and incubated for 8 h at 37°C with vigorous shaking 
(300 rpm). An aliquot (100 ul) of the starter culture was then added to 50 ml of LB/amp 
medium and grown for 16 hat 37°C with vigorous shaking (300 rpm). 
Bacterial cells were then harvested by centrifugation at 4500 x g for 20 min and 
the supernatant was discarded. The bacterial pellet was resuspended into 4 ml of Buffer 
Pl (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 100 ug/ml RNaseA) by pipetting up and 
down until no cell clumps remained. 4 ml of Buffer P2 (200 mM NaOH, 1 % SOS) was 
added and the sample was mixed gently by inverting 6 times, followed by incubation at 
room temperature for 5 min. Four ml of chilled Buffer P3 (3 M potassium acetate, pH 
5.5) was immediately added and mixed by inverting 6 times followed by incubation on 
ice for 20 min. The sample was centrifuged at 8200 x g for 25 min at 4 °C and the 
supernatant containing plasmid DNA removed immediately. The following steps were 
carried out in polypropylene tubes. A Qiagen-tip 100 was equilibrated by applying 4 ml 
of Buffer QBT (750 mM NaCl, 50 mM MOPS, pH 7.0, 15% isopropanol, 0.15% Triton 
X-100) and the column allowed to empty by gravity flow. The supernatant containing 
the plasmid DNA was then applied to the Qiagen-tip and allowed to filter through the 
resin by gravity flow. The Qiagen-tip was then washed twice with 10 ml of Buffer QC (1 
M NaCl, 50 mM MOPS, pH 7.0, and 15% isopropanol). 
The plasmid DNA was eluted from the resin using 5 ml of Buffer QF ( 1.25 M 
NaCl, 50 mM Tris-HCl, pH 8.5, 15% isopropanol) and transferred to non-polycarbonate 
tubes. The eluted DNA was then precipitated by adding 3.5 ml room-temperature 
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isopropanol. The solution was mixed gently by inversion and centrifuged immediately at 
8000 x g for 25 min at 4 °C, discarding the supernatant. The DNA pellet was washed 
with 2 ml of room temperature 70% ethanol and centrifuged at 15,000 x g for 10 min. 
The supernatant was decanted carefully so as no to disturb the pellet. The pellet was then 
air-dried in an inverted Eppendorf tube for 20 min and the plasmid DNA was 
resuspended in 100 µl of deionized water. 
Plasmids encoding the 151 construct were used as the template for preparation of 
the constructs encoding the 108 and 75 C-terminal residues of MUC5B. PCR was carried 
out using reactions described in Table 3-3 and primers shown in Table 1. PCR products 
were electrophoresed on 0.7% agarose gels as above and gels were examined under UV 
light. PCR products encoding the 108 and 75 C-terminal residues of MUC5B were 
extracted from the agarose and purified as described in Section 3.4; the purified DNA 
was then ligated into the TOPO vector and the resulting constructs were transformed into 
E. coli as described in Section 3.5. The presence of the 108 and 75 constructs in selected 
colonies was confirmed by PCR. 
3. 7 Plasmid Ligation 
Inserts in the TOPO constructs encoding the 151, 108 and 75 residues of MUC5B 
were excised by digestion with Barn Hl and Xhol and purified by agarose gel 
electrophoresis (Table 3-5). pGEX-5X-2 (Fig. 3-2) was the vector selected for expression 
studies in this investigation. This vector was digested with Barn H 1 and Xho 1 (Table 3-
5) and purified by agarose gel electrophoresis. 
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Each MUC5B insert was ligated into linearized pPGEX-5X-2 vector. The 
composition of the ligation reaction is given in Table 3-6. Ligated plasmids were used for 
transformation into E. coli (strain BL2 l ). The ratio of insert to vector was estimated to be 
approximately 3: 1. The ligation reaction was carried out at room temperature for 2 h. 
pGEX-5X·2 (27-4585-01) 
FactorXa 
, pGEX-5X·3 (27-4586-011 
factorXa 
l::e Giu Gly Argi ·1,1y lie Pro 
ATCGAA GGT CGT GGG ATC CCC 
Bam1o-. I 
pGEX-6P-1 (27-4597-011 
PreScis 1on rw 0 rotease 
PGEX-5X-2 Gly Arg lie Val -h , A o 
; GGC CGC ATC GTG ;,c r GA Ll 
Sma I a I Xl10 1 NO! I Si□p Odess 
lLeu Glu Val Leu Pse Gin ~Gly Pro I _eu G 'Y Se, P·o Glu Pne Pro Gly Mg Leu G u Arg Pro Hrs 
CTG AA GTT CTG ,C GAG GGG CCC CTG GG,, ICC CCG
1
GAA nr
1
CCG ,G
1
- CGA
1
qc GAG CGG CCG CAT 
8amH I EcoR I Sma I Sal I Xho I i'Joi I 
pGEX·6P·2 (27-4598-01 I 
PreSc,ss oa• Protease 
lteu GI Val Leu P~e Gin Gly ?ro I LeJ Gly Ser Pro Gly lie Pro Gly Ser T r Arq ~la r,1a Ala Ser 
CTG AA GTT C G TTC CAG GGG CCC C"G GGA -cc CCA GGA AT' CCC GGG "CG AC CG~ GCG GCC GCA TCG 
Barn"I ~
pGEX·6P·3 (27-4599-01) 
PreSc,ssion" Protea e 
lL.u Glu VaI Leu Phe Gin ·Sly Proll eu Gly er Pro Asn Se, A•g Val Asp Sa, er GJ' A-g 
CTG M GTT Cr::; rrc GAG GGG CCC CT GGA TCC CCG AA- ec C3G,G,TC GAF TCG App GuC CGC 
BamH I Econ I Sma I Sa I XhO I Nol I 
P-;t 
Mapo the glutathione S·transferase fusion vectors showing the reading frames and 
main features. Even though stop codons in all three frames are not depicted in this map 
a thirteen vectors have stop codons in all three frames downstream from the multiplE 
• ing site. 
Fi . 3-1 PGEX-SX-2 Vector Ma . 
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Table 3-5. Restriction digestions for MUCSB constructs and pGEX-SX-2. 
151, 108, 7 5 Constructs pGEX-5X-2 Vector 
1) 40 µl deionized water 1) 38 µl deionized water 
2) 5.0 µl l0x buffer* 2) 5.0 µl l0x buffer* 
3) 3.0 µl construct DNA (5 µg/µl) 3) 5.0 µl pGEX DNA (1 µg/µl) 
4) 1.0 µl Barn Hl (10 U/µl) 4) 1.0 µl Barn Hl (10 U/µl) 
5) 1.0 µl Xho 1 (10 U/µl) 5) 1.0 µl Xho 1 (10 U/µl) 
*l0x buffer: 500 rnM KCl, 100 rnM Tris-HCl (pH 9.0), 1 % Triton X-100 
Table 3-6. Ligation reaction. 
1) 3. 7 µ1 deionized water 4) 1. 5 µl ligase buff er 
2) 3.0 µ1151 insert 5) 1.0 µl ligase 
3) 2.0 µl pGEX-5X-2 
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3-8. Transformation Procedure 
Transformation was accomplished by combining ligated plasmids with competent 
E. coli (strain BL21) in a chilled Eppendorf tube. Cells were heat shocked at 42°C for 45 
sec and then placed on ice for 2 min. 250 µl of SOC medium was then added, and the 
culture allowed to incubate for 1 hour at 3 7°C. Colonies were prepared by spreading 50 
µl of the SOC medium onto one LB/amp plate and the remaining 200 µl of culture onto a 
second LB/amp plate. Two plates were used for each construct and these were incubated 
overnight at 3 7°C. 
In order to confirm successful transformation into BL21 (Table 3-7), 6 colonies 
from the plate containing the 151 construct and 4 colonies from the plates containing the 
108 and 75 constructs used as templates for PCR analysis in 25 µl reactions as described 
above. PCR products were electrophoresed on 0.7% agarose gels at 100 volts for 45 min 
and observed under UV-light. By reference to the 1 kb DNA ladder, the 151, 108 and 75 
constructs were predicted to contain 455 bp, 324 bp and 225 bp, respectively.Colonies of 
each construct were inoculated into SOC medium, composed of 800 µl SOC medium and 
200 µl glycerol, and stored at -80°C. 
SOC medium was prepared using the following procedure. 20 g of tryptone, 5 g 
of yeast extract, and 0.5 g of NaCl were combined into 1 liter of distilled water. The 
mixture was then divided into ten, 100 ml bottles and autoclaved at 180°C for 20 minutes 
at 15 psi. After the solution was cooled to 50°C, 1 M MgCh, 1 ml of sterile 250 mM KCl 
and 2. 78 ml of sterile 2 M (36%) glucose were added for each 100 ml of medium. 
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Table 3-7. BL21 strain E. coli PCR reactions. 
1) 17.0 µl deionized water 5) 0.5 µl 5' pGEX primer 
2) 2/ 5 µl 1 Ox buff er* 6) 0.5 µl 3' pGEX primer 
3) 1.5 µl MgC12 7) 0.25 µl Taq polymerase (1 U/µl) 
4) 0.5 µl dNTP (10 mM) 8) bacterial colony 
*lOX buffer: 500 mM KCl, 100 mM Tris-HCl (pH 9.0), 1% Triton X-100 
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3.9 Small Scale GST Fusion Protein Expression and Affinity Purification 
Each MUC5B protein construct is bound to Glutathione S-transferase (GST), 
expressed by the PGEX-5X-2 vector, as a fusion protein. GST possesses a mild affinity 
for glutathione Sepharose 4B which is suspended in a solid epoxy-based resin as part of a 
column filtration system (Fig. 3-3). In order to produce the fusion protein product, small 
test cultures from glycerol stocks were inoculated into 5 ml of 2X YTG medium and 
grown overnight at 37°C with agitation at 225 rpm. The next day, test cultures were 
added to 45 ml of fresh, pre-warmed medium and incubated at 37°C until OD600 reached 
approximately 1.0. 
2x YTG medium was prepared using the following procedure. 16 g of tryptone, 
10 g of yeast extract, and 5 g NaCl were combined in to 800 ml of distilled water. The 
mixture was then adjusted to pH 7.0 using NaOH and the volume adjusted to 900 ml. 
The medium was sterilized by autoclaving for 20 minutes and allowed to cool to 50°C, 
followed by the aseptic addition of 100 ml of sterile 20% glucose solution (final 
concentration of 2% ). Finally, 1 ml of 100 µ1/ml ampicillin stock solution was added. 
GST expression was induced with IPTG in order to promote synthesis of the 
fusion protein for each construct in BL-21 E. coli cells. Each 50 ml culture received 50 
µl of 100 mM IPTG for a final concentration of 0.1 mM IPTG. Cultures were incubated 
for 4 hours at 37°C; 1 ml samples were taken after 1 hour, 2 hours and 4 hours for SDS-
p AGE analysis of induction. Samples were placed in Eppendorf tubes and centrifuged at 
14000 x g for 5 min and the supernatant was discarded. Cell pellets were boiled for 5 
min and mixed with 20 µl of 6x DNA buffer to produce 25 µl samples which were 
electrophoresed on 10% polyacrylamide SDS gels at 70 V for 2½ hours. 
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Fig. 3-2 Illustration of Glutathione bonding 
with Sepharose 4B from Pharmacia Biotech 
GST manual. 
Fusion protein isolation was accomplished using the induction procedure above; 
after two hours of induction each culture was then transferred to a 50 ml Falcon tube and 
centrifuged at 8000 x g for 10 min at 4 °C. The supernatant was then discarded and the 
tubes were placed on ice. The cell pellets were resuspended in 2.5 ml of ice-cold lX 
phosphate-buffered saline (PBS; 10 mM Na2HPO4, 1.8 mM KH2PO4; 140 mM NaCl; 2.7 
mM KCl) at pH 7 .3 using a pi pet to mix. A Protease Inhibitor Cocktail (Calbiochem, La 
Jolla, CA; # 539131) was added prior to sonication to a final concentration of 1 mM of 
each inhibitor. The 2.5 ml suspensions were transferred to ice cold 14 ml Falcon tubes 
and sonicated with twelve , one second bursts , over ice in order to disrupt the E. coli cells 
and release the fusion protein. Then, Triton X-100 (20% solution; 125 µ1 per tube) was 
added to prevent formation of inclusion bodies and precipitation from the solution. Each 
tube was sealed with parafilm and incubated in an ice bath for 30 minutes while being 
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rocked on a platform. The tubes were then centrifuged at 8000 x g for 12 min; the 
supernatant was saved for chromatography on Sepharose 4B and 250 µl of each sample 
was set aside for SDS-PAGE analysis. 
A Bio-Rad SDS broad-range pre-stained standard (# 161-0318, control 96206) 
was used to assess the molecular weight of induced fusion protein. For all constructs the 
predicted and observed molecular mass of the fusion proteins was approximately 45 kDa. 
Of this, 26 kDa corresponded to the GST enzyme (fusion partner) and approximately 15-
18 kDa corresponded to the respective constructs. Eight samples, of 20 µl were analyzed 
by SDS-PAGE. Gels were stained with Bio-Rad Coomassie Brilliant Blue R-250 (#161-
0400) for 20 min and de-stained in 50% deionized water , 40% methanol , and 10% acetic 
acid. 
Affinity chromatography of the GST-proteins was accomplished using a 1 ml 
Sepharose GSTrap FF column (Amersham Biosciences, Piscataway, NJ; #17-5130-02). 
A Pharmacia Bio tech P 1 peristaltic pump ( # 18-1110-91) was employed to operate the 
column filtration system. The column was first equilibrated using 5 column volumes (5 
ml) of binding buffer (Ix PBS at pH 7.3) at a rate of 1-2 ml per min. Each 2.5 ml fusion 
protein sample was recycled through the column three times at a rate of 0.5 ml per min. 
The column was then washed with 5 volumes of binding buffer until no further OD280 
absorbing material appeared in the effluent. Each fusion protein construct was eluted 
from Sepharose 4B at a rate of 1 ml per min using 5 ml of elution buffer (50 mM Tris-
HCl, pH 8.0, containing 10 mM reduced glutathione) containing protease inhibitor 
cocktail. Eluate was collected in 1 ml increments and examined by SDS-PAGE. Later , 
samples were combined for dialysis. 
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Verification of fusion protein purification was accomplished on 12.5% 
polyacrylamide gels. Samples of 50 µ1 were prepared for five stages of purification: pre-
column sonicate , post-column sonicate, wash # 5, eluate #1, and eluate #2 . The gel was 
run at 70 V for 2 ½ hours. Eluate of column fractions containing fusion proteins was 
combined and dialyzed in Spectra/Por membrane tubing(# 132-676) with a MW cut-off 
of 12-14,000 Daltons against 2 L of deionized water at 4°C. The water was changed once 
over a 24 h period in order to remove glutathione and buffer salts. Dialyzed samples were 
then lyophilized overnight to yield the purified fusion proteins. 
Confirmation of the presence of GST bound fusion proteins was accomplished by 
Western blotting . Samples from the five stages above were subjected to SDS-PAGE. 
Proteins were transferred to a Protran ® nitrocellulose membrane (Schleicher & Schuell 
BioScience; Keene , NH; # 10401196). Transfer was accomplished electrophoretically at 
100 V for 1 h in buffer consisting of 3.03 g Tris, 14.4 g glycine and 200 ml methanol 
adjusted to a final volume of IL with deionized water. The membrane was then blocked 
in 5% milk-PBST for 1 h at room temperature and washed twice with PBST for 5 
minutes each. 
Incubation of the membrane with GST HRP monoclonal mouse antibodies (Santa 
Cruz Biotechnology; Santa Cruz, CA; sc-138 HRP # 11802) was performed at a dilution 
of 1 :5000 in 3% milk-PBST for 1 h at room temperature . The blot was dried and 
immersed for 20 seconds in 5 ml of Western Lightning ™ Chemiluminescence Reagent 
Plus (# NEL104) solution. Filter paper was then used to dry the membrane before 
wrapping it with plastic film. The blot was then placed in an X-ray film cassette and 
different comers of the film were placed over the blot for 1, 3, and 5 sec. The last 
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exposure was done by placing a paper sandwich between the film and blot followed by 
exposure for 1 sec. 
3.10. Small Scale Fusion Protein Cleavage and Construct Isolation 
In order to release MUC5B fragments from their GST fusion partners, activated 
Factor Xa (Amersham Biosciences, Piscataway, NJ; # 27-0849-01) was used. 
Lyophilized samples were dissolved in 5 µl and 10 µl of water and 90 µl of cleavage 
buffer (50 mM Tris-HCl, pH 8.0, containing 100 mM NaCl and 1 mM CaCh) and 2 µl of 
Factor Xa were added. As a control to test enzyme activity, trypsin was substituted for 
Factor Xa in one sample. The solutions were mixed gently and the reaction was carried 
out for 16 h at room temperature. 
Confirmation of the presence of MUC5B, before and after exposure to Factor Xa, 
was performed with a W estem Blot technique, using the membrane transfer as described 
in Section 3.9. Blotting was accomplished by immersing the membrane in 5% milk-
TBST overnight, followed by 3 washes of TBST for 10 min each. Primary antibody was 
anti-degly MG 1 (Troxler et al., 1995) used at a 1: 1000 dilution in 1 % milk-TB ST for 1 h 
at room temperature, followed by 3 washes of TBST for 10 min each. Secondary 
antibody was a monoclonal rabbit antibody coupled to alkaline phosphatase (AP) at 
1 :5000 dilution in 1 % milk-TBST for 1 h at room temperature, followed by 3 washes of 
TBST for 10 min each. Color development was with 10 ml of IX AP buffer, 66 µl of 
NBT, and 33 µl of BCIP. The blot was immersed in the staining solution until the 
desired reaction intensity was observed, and the reaction was stopped by immersing the 
blot in water. 
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In order to improve the efficiency of cleavage by Factor Xa, several denaturing 
agents were used as recommended in the GST Gene Fusion System 3rd Edition manual. 
Initially , SDS (0.5% w/v) was added to the reaction buffer and other denaturing agents 
were tried as well including 1 M - 2 M urea and 0.3% Triton X-100. In addition, one 
sample was boiled for 3 minutes in an attempt to denature the fusion protein prior to 
cleavage with Factor Xa. 
Enzyme effectiveness of Factor Xa was also tested in the presence of denaturants 
using a photo-reactive substrate, Pefachrome FXa (CenterChem; Norwalk, CT;# 08520-
I0UM-B). Using the reaction mixture in Table 3-8, reactivity of the substrate involved 
cleavage of a yellow dye (CH3OCO-D-CHA-Gly-Arg-pNA-AcOH) by Factor Xa which 
was measured with a Hitachi U-3010 spectrophotometer at OD405 in 20 sec increments 
for 10 min at room temperature. Factor Xa activity was also tested in the absence of 
denaturants and after standing at room temperature for 0 min, 1 h, 3 h at 18 h. Reaction 
conditions were identical to those above in the presence of denaturants. 
The assay buffer was prepared using the following procedure. Solution A was 
made by combining 4.04 g of Tris (hydroxymethyl)-aminomethane , 2.27 g of imidazole, 
and 1.95 g of NaCl; the total volume adjusted to 100 ml using deionized water. Solution 
B was made by combining 3.03 g of Tris, 1.7 g of imidazole, 50 ml of 1 N HCl, and 5.8 g 
of NaCl; the total volume was adjusted to 100 ml using deionized water. Solution B was 
then added to 8 ml of solution A until a pH of 8.4 was attained, producing a I0X Tris-
imidazole buffer . 
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Table 3-8. Pefachrome FXa substrate reaction mixture. 
1) 790 µl lx Tris-imidazole buffer 3) 10 µl Factor Xa 
2) 200 µl Pefachrome FXa 
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3.11. Large Scale Protein Expression and Affinity Purification 
Large cultures were grown for each construct using 40 ml of 2x YTG inoculated 
with the respective construct containing BL-21 culture from a glycerol stock overnight at 
3 7°C. Expression and induction procedures are identical to that of the small scale protein 
induction described in Section 3.9, increased in volume by 8 times. 360 ml of fresh 2x 
YTG was added for a total culture volume of 400 ml and incubated for 1 h at 37°C, 
before induction with 400 µl of IPTG for 1 h at 3 7°C. 
The culture was centrifuged and the cell pellet suspended in lx PBS, mixed with 
400 µl of protease inhibitor cocktail, and then sonicated with 12 bursts. The sonicate was 
then mixed with 1 ml of 20% Triton X-100 and incubated for 30 min before being 
centrifuged. The 20 ml of supernatant was recycled through the affinity column three 
times and the fusion proteins released in elution buffer. Eluates were dialyzed against two 
liters of deionized water and lyophilized. 
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4. Results 
4.1 Construct Synthesis and Amplification 
Sequences for the three C-terminal MUC5B constructs were generated from the 
web-based NCBI database (Accession# AF33402). The nucleotide sequences encoding 
the C-terminal 151 amino acid residues is shown in Fig. 4-1. 
When submandibular gland RNA was reverse transcribed into cDNA and the 
resulting cDNA was used as a template for PCR using primers shown in Table 3-1, a 
~450 hp DNA product was obtained (Fig. 4-2). The 450 hp DNA product was ligated into 
pCR®2.l-TOPO ® vector which was used to transform One Shot Chemically Competent 
E. coli. A subset of LB/ Amp plated cell colonies were selected and used as templates for 
PCR with pCR ®2.1-TOPO ® primers (Table 3-1) to confirm successful cloning of the 151 
construct. This experiment showed that all colonies contained a ~600 hp MUC5B DNA 
fragment (Fig. 4-3, panel A). Note that the pCR®2.1-TOPO® primers (i.e., M13 primers) 
added 132 hp to the 5' end and 90 hp to the 3' end. Therefore, the 600 hp PCR product is 
comprised of 455 MUC5B bps and 222 hp contributed by the pCR®2.l-TOPO ® vector. 
Two of these colonies were selected to inoculate a 50 ml LB/ Amp culture, and 
plasmids from the overnight grow were isolated as described in Materials and Methods 
(Section 3.6). Plasmids from one of these cultures were used to amplify the 108 and 75 
constructs; the MUC5B primers used for amplification are shown in Table 3-1. As above, 
the 108 and 75 PCR products were ligated into pCR®2.l-TOPO ® vector which was used 
to transform One Shot Chemically Competent E. coli cells. Four colonies from each plate 
(i.e., the 108 and 75 constructs) were selected and used as template for PCR with 
pCR®2.1-TOPO ® primers. The results showed that all selected colonies contained the 
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vector encoding the 108 and 75 inserts (Fig . 4-3, panel B, C). The PCR products 
corresponding to both the 108 and 7 5 construct appeared to be about 600 bp due to the 
presence ofpCR ®2.1-TOPO primers which add 222 bp to the size of the insert. 
Two LB/ Amp plated colonies of the 151, 108 and 7 5 constructs were used to 
inoculate 50 ml of LB/ Amp, and the cells were grown overnight. Plasmids were isolated 
from cells using the Plasmid Midi Qiagen Kit as described in Section 3.6. The yield of 
plasmid DNA was estimated spectrophotometrically from the formula: [DNA ug/ul] = 
(OD260 x Dilution Factor)/20). The yields of plasmid DNA in this experiment are given 
in Table 4-1. Each 30 ul sample of the various constructs contained from 1.5 to 5.0 ug/ul 
of plasmid DNA. 
Table 4-1. E.coli plasmid DNA yields with the 151, 108 
and 75 constructs. 
DNA Yield (µg/µl) 
151 
1. 
2. 
4.5 
5.0 
3.7 
3.8 
36 
4.4 
1.5 
TGC ACC GTG TAC CTC TGT GAG GCT GAG GGT GGA GTC CAT TTG 
m Cys Thr Val Tyr Leu Cys Glu Ala Glu Gly Gly Val His Phe 
CTG ACC CCA CAG CCT GCA TCC TGC CCA GAT GTG TCC AGC TGC AGG 
Leu Thr Pro Gln Pro Ala Ser Cys Pro Asp Val Ser Ser Cys Arg 
GGG AGC CTC AGG AAA ACC GGC TGC TGC TAC TCC TGT GAG GAG GAC 
Gly Ser Leu Arg Lys Thr Gly Cys Cys Tyr Ser Cys Glu 
- Asp 
TCC TGT CAA GTC CGC ATC AAC ACG ACC ATC CTG TGG CAC CAG GGC 
Ser Cys Gln Val Arg Ile Asn Thr Thr Ile Leu Trp His Gln Gly 
TGC GAG ACC GAG GTC AAC ATC ACC TTC TGC GAG GGC TCC TGC CCC 
Cys Glu Thr Glu Val Asn Ile Thr Phe Cys Glu Gly Ser Cys Pro 
GGA GCG TCC AAG TAC TCA GCA GAG GCC CAG GCC ATG CAG CAC CAG 
-
Ala Ser Lys Tyr Ser Ala Glu Ala Gln Ala Met Gln His Gln 
TGC ACG TGC TGC CAG GAG AGG CGG GTC CAC GAG GAG ACG GTG CCC 
Cys Thr Cys Cys Gln Glu Arg Arg Val His Gly Glu Thr Val Pro 
TTG CAC TGT CCT AAC GGC TCA GCC ATC CTG CAC ACC TAC ACC CAC 
Leu His Cys Pro Asn Gly Ser Ala Ile Leu His Thr Tyr Thr His 
GTG GAT GAG TGT GGC TGC ACG CCC TTC TGT GTC CCT GCG CCC ATG 
Val Asp Glu Cys Gly Cys Thr Pro Phe Cys Val Pro Ala Pro Met 
GCT CCC CCA CAC ACC CGT GGC TTC CCG GCC CAG GAG GCC ACT GCT 
Ala Pro Pro His Thr Arg Gly Phe Pro Ala Gln Glu Ala Thr Ala 
GTC TGA 
Val Stop 
Fig. 4-1 Nucleotide and amino acid sequence of the C-terminal region of MUCSB. 
Highlights indicate the first residue of the 151, 108, and 75 amino acid constructs. 
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bp: 
500 
M 2 3 
Fig. 4-2 Amplification of sequences encoding the C-terminal 151 of MUCSB. Lane 
M, 1 kb ladder standard; lane 2 and 3, DNA bands from different amplification reactions 
of the 151 construct. 
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bp: bp: 
600 
600 
Panel A Panel B 
bp: 
600 
Panel C 
Fig. 4-3 PCR of cells containing pCR2.1 TOPO vector encoding the 151, 108 and 75 
inserts. pCR2.1 TOPO primers (Table 4-2). were used in all PCR reactions. Panel A: 151 
construct; lane 1, 1 kb standard; lane 2-9, PCR products; Panel B: 108 construct; lane 1, 1 
kb ladder; lane 2-5, PCR products; Panel C: 75 construct; lane 1, 1 kb ladder; lane 2-5 , 
PCR products. 
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4.2 Cloning of Constructs into pGEX-SX-2 Expression Vector 
The 151,108 and 75 constructs in pCR2.l TOPO vector and pGEX-5X-2 were 
each digested with BamHl and Xhol (Table 3-6), and digests were electrophoresed in 
0. 7% agarose gels. Examination of gels under ultraviolet light revealed that the release of 
151, 108 and 75 inserts had occurred (Fig. 4-4, panel A, B, C) and that pGEX-5X-2 was 
linearized to an ~4900 bp product (Fig. 4-4, panel D). Insert and linearized pGEX bands 
were excised and purified using a Qiagen Gel Extraction Kit described in Section 3.4. In 
separate reactions, the 151, 108 and 75 constructs were ligated into pGEX-5X-2 and the 
respective ligation reactions were then used to transform E. coli, strain JM 109. Colonies 
were used to inoculate 50 ml LB/Amp cultures; plasmid DNA was isolated from cells and 
then sequenced. The nucleotide sequence of the 151 construct was copied into the 
ExPASy, translated into protein, and the in-frame sequence was found (Fig. 4-5). The 
translated amino acid sequence matched the published sequence except for several amino 
acid substitutions resulting from one base changes in a codon. The pGEX-5X-2 plasmid 
preparation encoding the 151 construct was re-sequenced and found to be identical to the 
first sequencing result (Fig. 4-6). 
Having confirmed in-frame cloning of the 151 construct, pGEX-5X-2 vector was 
used to transform E. coli, strain BL2 l, for expression studies. Colonies on LB/ Amp 
plates were used as template for PCR, and it was found that all BL2 l colonies contained 
an insert of the predicted size (Fig. 4-7). The same strategy was used to verify the 
presence of plasmids encoding the 108 and 75 constructs in BL-21 cells. Electrophoretic 
analysis of PCR products revealed significant bands of approximately 300 bp for the 108 
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construct and 200 bp for the 75 construct, corresponding closely to predicted values of 
324 bp and 225 bp, respectively. 
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bp: 
5000 
600 
Panel A 
Panel C 
bp: 
600 
bp: 
5000 
Panel B 
Panel D 
Fig. 4-4 E. coli plasmid and pGEX vector digestion. Panel A: 151 insert with TOPO 
vector, Panel B: 108 insert with TOPO vector, Panel C: 75 insert with TOPO vector, and 
Panel D: PGEX-5X-2 vector. 
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CGTATACCGAAACGCGCGAGGCANATCGTCAGTCAGTCACGATGCGGCCGCTCGAGTC 
AGACAGCAGTGGCCTCCTGGGCCGGGAAGCCACGGGTGTGTGGGGGAGCCATGGGCGC 
AGGGACACAGAAGGGCGTGCAGCCACACTCATCCACGTGGGTGTAGGTGTGCAGGATG 
GCTGAGCCGTTAGGACAGTGCAAGGGCACCGTCTCCTCGTGGACCCGCCTCTCCTGGC 
AGCAGGTGCACTGGTGCTGCATGGCCTGGGCCTCTGCTGAGTACTTGGACGCTCCGGG 
GCAGGAGCCCTCGCAGAAGGTGATGTTGACCTCGGTCTCGCAGCCCTGGTGCCACAGG 
ATGGTCGTGTTGATGCGGACTTGACAGGAGTCCTCCTCACAGGAGTAGCAGCAGTCAG 
TTTTCCTGAGGCTCCCCCTGCAGCTGGACACATCTGGGCAGGATGCAGGCTGTGGGGT 
CAGCAAATGGACTCCACCCTCAGCCTCACAGAGGTACACGGTGCAGTTCTGGATCCCA 
CGACCTTCGATCAGATCCGA 
Fig. 4-5 Nucleotide sequence of the 151 construct. The Barn HI (GGATCC) and Xhol 
(CTCGAG) sites are shown in bold face type groups and altered nucleotides as single 
bold face type. 
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5 '3' Original AA Sequence 
NCTVYLCEAEGGVHLLTPQPASCPDVSSCRGSLRKTGCC 
Y SCEE DSC QV RI NT TI L W HQ G CE TE VN IT F CE GS C PG AS 
K Y S A E A Q A Met Q H Q C T C C Q E RR V H E E T V P L H C P N G S A I L 
HTYTHVDECGCTPFCVPAPMclAPPHTRGFPAQEATAV 
Stop 
5 '3' Confirmation of Original AA Sequence 
NCTVYLCEAEGGVHLLTPQPASCPDVSSCRGSLRKTDCC 
Y SC EEDS C Q V RIN TT IL WH Q G CE TE VN I TF CE GS C P GAS 
K Y S A E A Q A Met Q H Q C T C C Q E R R V H E E T V P L H C P N G S A I L 
H T Y T H V D E C G C T P F C V P A P Met A P P H T R G F P A Q E A T A V 
Stop 
Fig. 4-6 Confirmation of MUCSB C-terminal amino acid sequences 5'-3'. Amino 
acid substitution noted in bold and underlined text. 
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Fig. 4-7 BL21 E. coli transformation with MUC5B constructs. Panel A: 151 insert , 
Panel B: 108 insert , and Panel C: 75 insert. 
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4.3 Protein Expression 
BL21 cells transformed with empty pGEX-5X-2 or the 151 construct in pGEX-
5X-2 were examined in expression studies. Cells were grown to an A600 of 0.5-1.0 (mid 
log phase), induced with IPTG and 1 ml aliquots of the culture were removed at various 
times. SDS-PAGE analysis of protein expression of GST in empty vector and the 151 
fusion protein in BL-21 demonstrated significant induction over a 4 h time period (Fig. 4-
8). Lanes 1-4 show extracts of cells containing the empty pGEX-5X-2 vector 0, 1, 2 and 
4 h after the addition of IPTG. Lanes 5-8 show extracts of cells containing the 151 
construct 0, 1, 2 and 4 h after the addition of IPTG. A progressively larger quantity of the 
29 kDa GST protein was observed with increasing induction time whereas the quantity of 
45 kDa fusion protein appeared to reach maximal levels after only 1 h of induction (Fig. 
4-12; arrows). At the end of the 4 h induction period both the 29 kDa GST and 45 kDa 
151 fusion protein became the predominant cellular proteins reaching levels up to 5 
ug/ml of culture. 
Similar expression studies were carried out using the 108 and 75 kDa constructs 
(Fig. 4-9). As above, cells were grown to mid-log phase, induced with IPTG and 1 ml 
aliquots of the culture were removed at various times. SDS-PAGE analysis of cells 
showed that uninduced cells contained minute quantities of recombinant proteins, 
whereas maximum induction levels of the 45 kDa fusion proteins were observed after 
treatment with IPTG at 1 h. It should be noted that the SDS-PAGE gels used for these 
analyses were not able to distinguish between the molecular weight of the 151, 108 and 
75 fusion proteins. 
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Fig. 4-8 IPTG induction of 151 construct. The prestained broad range marker s 
(BioRad) were: myosin , 207 kDa ; ~-galactosidase , 119 kDa ; bovine serum albumin , 66 
kDa; ovalbumin , 57.5 kDa ; carbonic anhydrase , 38.6, soybean trypsin inhibitor , 29 kDa ; 
lysozyme , 20 kDa ; approtinin = 7 kDa . Lane M, standard ; lanes 1-4: induction of empty 
pGEX-5X-2 fusion protein at 0, 1, 2 and 4 h; lanes 5-8: induction of 151 fusion protein at 
0, 1, 2 and 4h. 
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Fig. 4-9 IPTG induction of 108 and 75 constructs. The prestained broad range markers 
(BioRad) were: myosin , 207 kDa; ~-galactosidase , 119 kDa ; bovine serum albumin , 66 
kDa; ovalbumin , 57.5 kDa; carbonic anhydrase , 38.6 , soybean trypsin inhibitor , 29 kDa ; 
lysozyme , 20 kDa; aprotinin = 7 kDa. Lane M, standard; lanes 1-4: induction of 108 
fusion protein at 0, 1, 2 and 4 h; lanes 5-8: induction of 75 fusion protein at 0, 1, 2 and 
4h. 
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4.4 Affinity Purification 
The 151, 108 and 7 5 recombinant fusion proteins were purified from cell extracts 
of 50-400 ml cultures on Sepharose 4B GSTrap affinity columns. Manufacturer's 
specifications for affinity recovery of GST fusion proteins are shown in Figure 4-10. 
Initial affinity column experiments revealed minimal yields of recombinant proteins 
based on the appearance of Coomassie Blue stained gels. Several approaches were taken 
to address this problem because high levels of expression were observed in cell extracts. 
As recommended by the manufacturer, DTT was added to the cell suspension before 
sonication but this did not result in increased binding efficiency. 
An additional experiment was carried out to examine the effect of the number of 
sonication cycles on release of recombinant fusion proteins. The original protocol called 
for cell disruption by 36 bursts of one second each. It is well recognized that over-
sonication can potentially trap recombinant proteins in micelles formed from bacterial 
membrane lipids. To address this issue, the experiment was performed with cells 
containing the 151 construct that were induced for lh and then subjected to 12, 24 or 36 
sonication---bursts. Extracts of cells subjected to this sonication regime were centrifuged 
and the supematants were examined by SDS-P AGE. Proteins were transferred to 
nitrocellulose membranes and probed with rabbit polyclonal antibodies against GST and 
against deglycosylated MG 1. Blots examined on X-ray film revealed that the highest 
recovery of recombinant proteins occurred when cells were subjected to only 12 
sonication bursts, and there appeared to be an exponential reduction in recovery of 
recombinant protein after 24 and 36 bursts. Therefore in all subsequent experiments, cell 
disruption was limited to 12 one second bursts. 
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Fig. 4-10 Graph of affinity column yields from the Pharmacia Gene Fusion System 
manual 3rd Ed. Rev. 1. 
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Fig. 4-11 Western Blot analysis of 151 fusion protein sonication. Lane M, sample; 
lanes 1-3: pre-column sonicate, post-column sonicate, and 2nd eluate using 12 bursts; 
lanes 4-6: pre-column sonciate, post-column sonicate, and 2nd eluate using 24 bursts; 
lanes 7-9: pre-column sonicate, post-column sonicate, and 2nd eluate using 36 bursts. 
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Once the sonication process had been optimized the yields of GST fusion proteins 
after affinity purification were estimated to be approximately of lµg/µ1. Initial high-yield 
affinity purifications produced several by-products , in addition to the desired 44-45 kDa 
fusion proteins. A 30 kDa band was noted consistently and assumed to be the GST fusion 
partner protein only. When Western blots of affinity purified protein preparations were 
probed with rabbit polyclonal anti-GST antibodies ( coupled to HRP) the 30 kDa band 
was immunoreactive confirming that this band was indeed GST. Several minor bands on 
Coomassie Blue stained gels of affinity purified fusion proteins did not react with the ant-
GST antibodies and likely represent E. coli protein contaminants. 
Additional experiments were carried out where cell lysates of induced E. coli cells 
containing the 151 construct were subjected to three cycles of affinity column 
purification. SOS-PAGE analysis of the affinity purified material showed that the 45 
kDa fusion protein was the predominant species present (Fig. 4-12) . A series of barely 
detectable Coomassie Brilliant Blue bands were observed below 45 kDa that may be 
attributable to proteolysis of the 45 kDa fusion protein. This occurred despite the fact that 
proteas e-inhibitors (lmM AEBSF) were added to cell susupensions before sonication and 
to buffers used for affinity purification. Another series of very faint Coomassie Brilliant 
Blue bands were observed above the 45 kDa fusion protein. Since these bands did not 
react with anti-GST antibodies they likely represent E. coli chaperone proteins. 
A similar series of experiments was carried out on affinity purification of the 108 
and 75 constructs. Briefly , cells were grown to mid log phase, induced with IPTG for 1 h 
and cells were collected by centrifugation. Cell pellets were resuspended in PBS 
containing protease inhibitors and disrupted by sonication as above. Broken cell 
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preparations were centrifuged and fusion proteins in the supernatant were purified by 
affinity chromatography on Sepharose 4B columns (Fig. 4-13). The second eluate was 
used , since it provided the greatest yield of fusion protein. As noted with the 151 
construct , affinity chromatography effectively removed most E. coli proteins. However, 
affinity purified samples contained nearly equal amounts of the 44-45 kDa fusion 
proteins and the 30 kDa GST fusion partner (Fig. 4-13 , lane 4, 8). The reason for this is 
not known. One possibility might be that the original 108 and 7 5 E. coli colonies selected 
for expression studies may in fact have contained cells harboring the 108 and 75 
constructs as well as cells harboring empty vector. 
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M 1 2 3 4 5 6 
Fig. 4-12 151 fusion protein affinity purification. Lane M, standard; lane 1, pre-
column sonicate; lane 2, post-column sonicate; lane 3, 5th wash; lane 4, 1st eluate; lane 5, 
2nd eluate; lane 6, 3rd eluate. 
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Fig. 4-13 108 and 75 fusion protein affinity purification. Lane M, standard ; lanes 1-4: 
pre-column sonicate , post-column sonicate , 1st wash , 2nd eluate of 108 FP; lanes 5-8: pre-
column sonicate , post-column sonicate , 1st wash , 2nd eluate of 75 FP. 
55 
4.5 Fusion Protein Cleavage 
Fusion protein cleavage for PGEX-5X-2 utilized activated Factor Xa in order to 
separate the 151, 108 and75 constructs from their GST fusion partners. Initial cleavage 
experiments used 8 µl of the Factor Xa enzyme. However, analysis of enzyme digests by 
SOS-PAGE on Coomassie Brilliant Blue stained gels revealed little or no observable 
decrease in fusion protein concentration, even after reactions had been incubated for 16 h 
(Fig. 4-14). A prominent band of 29 kDa, attributable to Factor Xa enzyme, was observed 
in all digests and none of the digests contained the ~ 15 kDa recombinant proteins that 
should have been released by enzymatic cleavage of fusion proteins (Fig. 4-14, lane 3, 5, 
7). In order to evaluate whether fusion proteins were susceptible to proteolysis of any 
kind, the 151 fusion protein was digested with trypsin. This resulted in the complete 
disappearance of the 45 kDa fusion protein (Fig. 4-14, lane 1). Consequently, the lack of 
Factor Xa activity was suspected to be a problem related accessibility of the cleavage site 
rather than to proteolysis resistance. 
To verify that the 45 kDa protein induced with IPTG at 37°C was indeed the GST 
enzyme attached to the 151, 108 and 75 amino acid residue portions ofMUC5B, Western 
blot of affinity purified fusion proteins were probed with rabbit polyclonal anti-MUC5B 
antibodies (Fig. 4-15). These experiments showed that the 44-45 kDa fusion proteins 
corresponding to the 151, 108 and 75 constructs were immunoreactive with the anti-
MUC5B antibodies (Fig. 4-15, lane 1-6) but that digestion with factor Xa did not cleave 
these recombinant proteins from their fusion proteins (Fig. 4-15, lane 2, 4, 6). 
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Fig. 4-14 151, 108, 75 fusion protein cleavage. Lane M, standard ; lane 1, trypsin 
cleavage ; lanes 2-3: pre-cleavage , post-cleavage 151 FP; lanes 4-5: pre-cleavage , post-
cleavage 108 FP; lanes 6-7: pre-cleavage , post-cleavage 75 FP. 
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Fig. 4-15 Anti-MUC5B Western Blot of 151, 108, and 75 fusion protein cleavage. 
Lane M, standard; lanes 1-2, pre-cleavage and post-cleavage of 151 FP; lanes 3-4, pre-
cleavage and post-cleavage of 108 FP; and lanes 5-6, pre-cleavage and post-cleavage of 
75 FP. 
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Several additional experiments were carried in order to improve enzyme activity. 
Fusion proteins were digested with Factor Xa in the presence of 0.5% SDS and 0.3% 
Triton X-100 but this resulted in no appreciable improvement (data not shown). 
An additional series of experiments were carried out with the 151 construct where 
cells were induced with IPTG at 27°C and 30°C (for 1, 2, 4 and 6 h) rather than the 
standard temperature of 3 7°C. This modification was tested because it is known that the 
induction temperature can cause improper folding of the fusion proteins resulting in 
masking of the Factor Xa cleavage site. Examination of cells containing the 151 construct 
induced with IPTG at the lower temperatures on Coomassie Brilliant Blue stained gels 
showed essentially no production of fusion proteins (Fig. 4-16). Therefore, this approach 
was abandoned. 
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Fig. 4-16 151 fusion protein induction at 27° and 30°C. Lane M, standard; lane 1, 
uninduced; lanes 2-5: induction at 1, 2, 4 and 6 hat 27°C; lanes 6-9: induction at 1, 2, 4 
and 6 h at 30°C. 
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4.6 Factor Xa Activity Studies 
In order to assess whether the inability of Factor Xa to cleave the 151, 108 and 75 
fusion proteins, a series of experiments was carried out to test the activity of the 
commercially obtained Factor Xa preparation using a synthetic substrate. Since the 
protocol for cleavage of fusion proteins recommends incubation with Factor Xa for 16 h, 
the stability of the enzyme as a function of time was assessed (Fig. 4-17). Factor Xa 
activity was measured with the Pefachrome ( artificial) substrate immediately after 
bringing the enzyme to room temperature. The activity versus time curve was hyperbolic 
indicative of Michaelis-Menten kinetics but after standing at room temperature for 1 h, 
the activity versus time curve was essentially linear (Fig. 4-17, panel A, B). Incubation of 
Factor Xa at room temperature for 3 h did not result in significant reduction of activity 
from the 1 h measurement but when the enzyme was allowed to stand at room 
temperature for 18 h, there was no residual enzymatic activity (Fig. 4-17, panel C, D). 
This raised serious questions about the recommended incubation times for cleavage of 
fusion proteins with Factor Xa. It also raised questions regarding the use of denaturants in 
the cleavage buffer to expose Factor Xa sites in the recombinant fusion proteins. 
In order to examine this issue, Factor Xa activity was measured using the artificial 
substrate Pefachrome in reaction mixtures containing IM or 2M Urea or 0.3% Triton X-
100. The control experiment showed that the Factor Xa preparation was active and 
exhibited Michaelis-Menten kinetics whereas addition of 1 M or 2M urea to the reaction 
mixtures essentially abolished enzyme activity (Fig. 4-18, panel A). When Factor Xa 
activity was measured in the presence of 0.3% Triton X-100, the reaction kinetics were 
linear and total activity was less than that observed when the enzyme was allowed to 
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stand at room temperature in reaction buffer (minus denaturants) for 3 h (Fig. 4-18 , panel 
B). These results show that addition of denaturants to reaction mixtures to expose Factor 
Xa sites is counterproductive because these agents have a denaturing effect on the 
enzyme. 
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Fig. 4-17 Spectophometric analysis of Factor Xa activity. Panel A: activity at O h; 
Panel B: activity at 1 h; Panel C: activity at 3 h; Panel D: activity at 18 h. 
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Fig. 4-18 Factor Xa activity in the presence of denaturants. Panel A: activity in OM 
(top curve) , 1.0 M Urea (middle curve) and 2.0 M Urea (bottom curve); Panel B: activity 
in 0.3% Triton X-100. 
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4. 7 Large Scale Production of Fusion Proteins 
After several unsuccessful attempts to cleave the fusion protein of each construct , 
the Factor Xa reaction was abandoned. Instead , it was determined that the constructs 
would be used for antibody production as GST fusion proteins. Large cultures ( 400 ml) 
induced with IPTG and fusion proteins in supematants of sonicated cell preparations 
were affinity purified. Analysis of Coomassie Brilliant Blue stained gels confirmed the 
presence of the 151 (Fig. 4-19) , 108 (Fig. 4-20) and 75 (Fig. 4-21) fusion proteins. The 
second and third eluate samples were used since they provided the greatest yield. Protein 
degradation was noted , consistent with previous yields from smaller cultures. 
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Fig. 4-19 SOS-PAGE gel of 400ml culture 151 fusion protein affinity column 
isolation. Lane M, standard; lane 1, pre-column sonicate; lane 2, post-column sonicate; 
lane 3, 5th wash; lane 4, 2nd eluate; lane 5, 3rd eluate. 
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Fig. 4-20 SOS-PAGE gel of 400ml culture 108 fusion protein affinity column 
isolation. Lane M, standard; lane 1, pre-column sonicate ; lane 2, post-column sonicate ; 
lane 3, 5th wash; lane 4, 2nd eluate; lane 5, 3rd eluate. 
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Fig. 4-21 SDS-PAGE gel of 400ml culture 75 fusion protein affinity column 
isolation. Lane M, standard ; lane 1, pre-column sonicate ; lane 2, post-column sonicate ; 
lane 3, 5th wash ; lane 4, 2nd eluate ; lane 5, 3rd eluate. 
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5. Discussion 
The current experiment has demonstrated that fusion protein isolation from 
cultures of BL-21 transformed with MUC5B constructs, contained within a PGEX-5X-2 
vector, is attainable using the recommended protocols. Initial DNA sequencing and 
amplification of the three constructs was successful and provided an experimentally 
useful yield for further applications. TOPO cloning was required due to the inability of 
the standard RT-PCR to amplify the 108 and 7 5 construct configuration. The weak 
bonding nature of the single deoxyadenosine (A), added to the ends of the PCR product 
by Tag polymerase, and the thymidine (T) present in linearized TOPO vector residues 
(Strissel et al., 1998) allowed for successful plasmid integration during ligation. With a 
stable foundation for amplification, DNA isolated from TOPO cloned plasmids was used 
as an RT model for the PCR of the 108 and 75 constructs. 
Plasmid extraction provided ample DNA samples for ligation in to pGEX-5X-2, a 
vector selected for its GST domain and the presence of Barn Hl and Xho 1 ligation sites 
that were designed in to the original sequence of each construct. PGEX vectors 
incorporate lacfl, a gene that has no specific host cell requirements for plasmid 
propagation or fusion protein expression. PGEX is designed to be inducible and produce 
high intracellular yields of gene and gene-fragment products. Protein expression is 
controlled by the tac promotor and induced by isopropyl ~-D-thiogalactoside (IPTG) 
(Gentry and Burgess, 1990). BL-21 E. coli strain is recommended for the expression of 
GST fusion proteins, though transformation capacity is limited. An alternate strain is 
recommended for plasmid maintenance; in this experiment, JM 109 was used. Cultures 
were allowed to grow until an approximate mid-logarithmic phase in order to maximize 
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viable colonies for expression and minimize toxicity from over-growth ( de Carlos et al., 
2003). 
It should be noted that the SOS-PAGE gels used for these analyses were not able 
to distinguish between the molecular weight of the 151, 108 and 7 5 fusion proteins. This 
could be related to the resolving power of the electrophoresis system or to structural 
features of the recombinant proteins, or both. 
The effects of sonication on fusion protein isolation revealed that excessive cycles 
(24 or 36x) resulted in non-detectable yields, using Coomassie PAGE stain analysis. It is 
believed that sonication may have denatured the GST portion of the fusion protein 
(Mercado-Pimentel et al. 2002), demonstrated by Wes tern Blot analysis of the yields 
found in later experiments that used fewer cycles (12x). 
Solubility is also a concern, as eukaryotic proteins expressed in E. coli are often 
insoluble , possibly as a result of rapid overexpression caused by strong bacterial 
promoters, incorrect folding of the initial peptide, or lack of posttranslational alterations 
that could result in increased overall polarity (Frangioni and Neel, 1993). Triton X-100, 
a non-ionic micelle-forming detergent, assists in minimizing polarity-associated 
interactions, and the resultant formation of insoluble inclusion bodies (Kromer et al., 
1997). Sufficient aeration, resulting in higher oxygen transport, is thought to improve 
protein solubility. A lack of solubility in the column buffer would result in failure of the 
GST fusion proteins to bind to the sepharose column. Attempts to increase the binding 
efficacy of the fusion proteins resulted in the addition of DTT prior to sonication. 
GST fusion proteins are responsive to immunoassay or colorimetric assay 
detection. Conditions for elution are characteristically very mild and non-denaturing, 
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minimizing the effects on antigenicity and functional activity. Fusion proteins are 
designed to be purified by either a batch method, using a variable amount of Glutathione 
Sepharose 4B, or with column chromatography. Yields are highly variable, dependent on 
the nature of the particular fusion protein, the host cell, and the culture conditions (Smith 
and Johnson, 1988). 
The pGEX-5X-2 plasmid was designed to react with Factor Xa, possessing the 
recognition sequence Ile-Glu-Gly-Arg for site-specific cleavage, located upstream from 
the pGEX multiple cloning site. Digestion reactions may be performed while the fusion 
protein is bound to the sepharose 4B or after it is eluted from the matrix (Smith, 1993). 
In all the reactions performed for fusion protein cleavage, no significant yields of the 
isolated construct could be observed, and, therefore indicated that the Factor Xa was not 
functioning effectively. 
The primary consideration for the lack of Facter Xa enzyme action was proposed 
to involve the accessibility of the cleavage binding site. Intra-molecular folding of the 
protein was postulated, most likely during protein expression, as a primary cause for the 
masking of the enzyme-recognition site interface of Factor Xa, thereby prohibiting 
cleavage. In order to modulate protein expression, induction temperatures were lowered 
in to slow post-translational alterations, theoretically producing a product with less intra-
molecular folding. Temperature ranges of 27° and 30°C were discovered to be too low, 
as induction did not produce appreciable amounts of the fusion protein, even after 6 
hours. 
In order to allow better enzyme-protein interaction, a series of denaturants was 
used in order to break up the intra-molecular bonds. The amount of denaturant was 
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critical, as too high a concentration would result in the inhibition of Factor Xa activity 
and a resultant lack of fusion protein cleavage; conversely, too low a concentration would 
not sufficiently disrupt intra-molecular folding. In addition to denaturants, the presence 
of buffer salts, glutathione in particular, may inhibit enzyme activity; as a result, all 
samples were dialyzed against deionized water in order to remove any soluble salts 
present and then lyophilized to produce the isolated eluate protein. 
Protein expression in various colonies of E. coli can vary; certain colonies may 
have a mutation that is biased towards expression of primarily GST, while others may 
produce mostly fusion protein. Selection for various mutant strains can be accomplished 
by performing test cultures using BL21 colonies plated on to an LB+ AMP agar medium 
and observing protein expression using PAGE. 
MUC5B constructs, with their GST fusion partner, were isolated for polyclonal 
antibody studies in rabbits. Despite the attempt to produce an isolated MUC5B construct, 
GST fusion proteins may be used in functional tests in most cases (Pharmacia, 1997). 
Antibodies to the fusion protein may be separated from the MUC5B construct antibodies 
using affinity column filtration. Isolated MUC5B constructs may then be immunized 
directly in to rabbits and their antibodies used to probe for the presence of cystine-knot 
motifs based on the size of the construct. Specifically, studies might reveal the effects a 
shortened peptide construct would have on the conformation of the cystine-knot motif in 
order to evaluate its critical structural components. 
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